0001493152-21-016651.txt : 20210712 0001493152-21-016651.hdr.sgml : 20210712 20210712171121 ACCESSION NUMBER: 0001493152-21-016651 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210712 FILED AS OF DATE: 20210712 DATE AS OF CHANGE: 20210712 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Townsend John CENTRAL INDEX KEY: 0001511906 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40582 FILM NUMBER: 211086146 MAIL ADDRESS: STREET 1: 15150 AVENUE OF SCIENCE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92128 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Unicycive Therapeutics, Inc. CENTRAL INDEX KEY: 0001766140 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813638692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5150 EL CAMINO REAL, SUITE A-32 CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 650-384-0642 MAIL ADDRESS: STREET 1: 5150 EL CAMINO REAL, SUITE A-32 CITY: LOS ALTOS STATE: CA ZIP: 94022 3 1 ownership.xml X0206 3 2021-07-12 0 0001766140 Unicycive Therapeutics, Inc. UNCY 0001511906 Townsend John C/O UNICYCIVE THERAPEUTICS, INC. 5150 EL CAMINO REAL SUITE A-32 LOS ALTOS CA 94022 0 1 0 0 Chief Financial Officer Employee Stock Option (right to buy) 7.01 2031-03-01 Common Stock 23256 D Twenty-five percent (25%) of the stock options vest on March 1, 2022, and the remaining seventy-five percent (75%) of the stock options vest in successive equal monthly installments over the following thirty-six (36) months, until the options become fully vested on March 1, 2025. /s/ John Townsend 2021-07-12